CHP
DMK
Cable Hill Partners’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-20,000
| Closed | -$7K | – | 96 |
|
|
2020
Q1 | $7K | Hold |
20,000
| – | – | ﹤0.01% | 91 |
|
|
2019
Q4 | $14K | Buy |
20,000
+6,000
| +43% | +$4.2K | ﹤0.01% | 105 |
|
|
2019
Q3 | $10K | Buy |
14,000
+4,000
| +40% | +$2.86K | ﹤0.01% | 107 |
|
|
2019
Q2 | $13K | Sell |
10,000
-8,000
| -44% | -$10.4K | ﹤0.01% | 115 |
|
|
2019
Q1 | $38K | Hold |
18,000
| – | – | 0.01% | 287 |
|
|
2018
Q4 | $41K | Buy |
18,000
+8,000
| +80% | +$18.2K | 0.02% | 261 |
|
|
2018
Q3 | $31K | Buy |
10,000
+6,000
| +150% | +$18.6K | 0.01% | 249 |
|
|
2018
Q2 | $13K | Hold |
4,000
| – | – | 0.01% | 422 |
|
|
2018
Q1 | $14K | Sell |
4,000
-3,000
| -43% | -$10.5K | 0.01% | 413 |
|
|
2017
Q4 | $34K | Buy |
7,000
+5,000
| +250% | +$24.3K | 0.01% | 289 |
|
|
2017
Q3 | $10K | Buy |
+2,000
| New | +$10K | ﹤0.01% | 592 |
|